In this regard, we used the novel strategy that the tumor vaccine B16F10/GPI-IL-21 was combined with overexpression of miR200c or knockdown of ZEB1 to evaluate the synergitic efficacy of treatment of murine melanoma, and to attempt to investigate the molecular mechanisms of melanoma metastasis in the present study. This evidence concerns the gene ZEB1 and melanoma.